Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

US Patent 11059906 · Granted Jul 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and apparatus for sewing book blocks without blind stitch by means of hoo2025
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute in2025
Compositions for increasing half-life of a therapeutic agent in felines and meth2025
Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treat2025
Polynucleotides encoding Citrin for the treatment of Citrullinemia type 22025
Adeno-associated virus compositions for restoring HBB gene function and methods 2025
Adeno-associated virus compositions for restoring PAH gene function and methods 2025
Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome2024
Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia2024
Adeno-associated virus compositions for restoring PAH gene function and methods 2024
Adeno-associated virus compositions for PAH gene transfer and methods of use the2024
Adeno-associated virus compositions for PAH gene transfer and methods of use the2024